The increasing use of anticonvulsant drugs in psychiatry has prompted great
er awareness of their effects on a range of psychiatric domains, including
cognition. Older versus newer antiepileptic drugs have been reported to eit
her worsen or enhance cognitive performance in clinical populations, and th
e extent to which cognitive disturbances may reflect iatrogenic factors ver
sus psychopathology is subject to debate. We review current information abo
ut the role of anticonvulsants in cognition, with particular emphasis on ne
wer compounds (such as lamotrigine, gabapentin, and topiramate), the cognit
ive dimensions of affective illness, and the clinical approach to evaluatin
g cognition in psychiatric patients taking anticonvulsant drugs over time.